Lv31
246 积分 2022-08-09 加入
Efficacy and Safety of Tunlametinib in Adults with Inoperable Neurofibromatosis Type 1–Associated Plexiform Neurofibromas: Phase IIa Trial and Biomarker Research
1小时前
已完结
Pharmacokinetics, Metabolism, and Excretion of Irinotecan (CPT-11) Following I.V. Infusion of [14C]CPT-11 in Cancer Patients
3个月前
已关闭
BRAF-MUTANT METASTATIC NON–SMALL-CELL LUNG CANCER: REAL WORLD DATA FROM THE ITALIAN BIOMARKER ATLAS DATABASE
3个月前
已完结
Targeting the MAPK Pathway for NRAS Mutant Melanoma: From Mechanism to Clinic
4个月前
已完结
Multimodal treatment with thiotepa, bevacizumab, teniposide, and tunlametinib in a patient with neurofibromatosis type 1-associated oligodendroglioma: a rare case report
4个月前
已完结
Type II RAF inhibitor tovorafenib for the treatment of pediatric low-grade glioma
4个月前
已完结
Tovorafenib: First Approval
4个月前
已完结
Operational characteristics of full random effects modelling (‘frem’) compared to stepwise covariate modelling (‘scm’)
4个月前
已完结
FDA new drug approvals in Q2 2025
4个月前
已完结
FDA approves 100th small-molecule kinase inhibitor
4个月前
已完结
皖公网安备34019202002308
